carnitine has been researched along with Celiac Sprue in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Thirty celiac disease patients received 2 g daily, 180 days (L-carnitine group) and 30 were assigned to the placebo group (P group)." | 9.12 | L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study. ( Bucci, C; Calvani, M; Ciacci, C; Iannoni, E; Iovino, P; Margarucci, S; Peluso, G; Rispo, A; Siniscalchi, M; Tortora, R; Zingone, F, 2007) |
| "To determine the fasting plasma carnitine ester in patients with celiac disease." | 7.73 | Plasma carnitine ester profile in adult celiac disease patients maintained on long-term gluten free diet. ( Bene, J; Gasztonyi, B; Juhász, M; Komlósi, K; Melegh, B; Tulassay, Z, 2005) |
| "Carnitine is a very important co-factor for the metabolism of fatty acids, because it is the necessary carrier for the passage of acyl groups inside the mitochondria, where beta-oxidation takes place." | 5.28 | [Plasma L-carnitine levels in children with celiac disease]. ( Assanta, N; Ceccarelli, M; Cortigiani, L; Nutini, P; Ughi, C, 1992) |
| " Thirty celiac disease patients received 2 g daily, 180 days (L-carnitine group) and 30 were assigned to the placebo group (P group)." | 5.12 | L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study. ( Bucci, C; Calvani, M; Ciacci, C; Iannoni, E; Iovino, P; Margarucci, S; Peluso, G; Rispo, A; Siniscalchi, M; Tortora, R; Zingone, F, 2007) |
| "To determine the fasting plasma carnitine ester in patients with celiac disease." | 3.73 | Plasma carnitine ester profile in adult celiac disease patients maintained on long-term gluten free diet. ( Bene, J; Gasztonyi, B; Juhász, M; Komlósi, K; Melegh, B; Tulassay, Z, 2005) |
| "Duodenal biopsy was compatible with gluten enteropathy." | 1.33 | Encephalopathy due to carnitine deficiency in an adult patient with gluten enteropathy. ( Erdem, S; Kansu, T; Karakoç, E; Sökmensüer, C, 2006) |
| "Carnitine is a very important co-factor for the metabolism of fatty acids, because it is the necessary carrier for the passage of acyl groups inside the mitochondria, where beta-oxidation takes place." | 1.28 | [Plasma L-carnitine levels in children with celiac disease]. ( Assanta, N; Ceccarelli, M; Cortigiani, L; Nutini, P; Ughi, C, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fitzgerald, JF | 1 |
| Troncone, R | 1 |
| Roggero, P | 1 |
| Pozzi, E | 1 |
| Garavaglia, B | 1 |
| Parini, R | 1 |
| Carissimi, E | 1 |
| Santus, F | 1 |
| Piemontese, P | 1 |
| Cataliotti, E | 1 |
| Mosca, F | 1 |
| Carnelli, V | 1 |
| Karakoç, E | 1 |
| Erdem, S | 1 |
| Sökmensüer, C | 1 |
| Kansu, T | 1 |
| Bene, J | 1 |
| Komlósi, K | 1 |
| Gasztonyi, B | 1 |
| Juhász, M | 1 |
| Tulassay, Z | 1 |
| Melegh, B | 1 |
| Ciacci, C | 1 |
| Peluso, G | 1 |
| Iannoni, E | 1 |
| Siniscalchi, M | 1 |
| Iovino, P | 1 |
| Rispo, A | 1 |
| Tortora, R | 1 |
| Bucci, C | 1 |
| Zingone, F | 1 |
| Margarucci, S | 1 |
| Calvani, M | 1 |
| Bach, AC | 1 |
| Babayan, VK | 1 |
| Ottery, FD | 1 |
| Lerner, A | 1 |
| Gruener, N | 1 |
| Iancu, TC | 1 |
| Ceccarelli, M | 1 |
| Cortigiani, L | 1 |
| Assanta, N | 1 |
| Nutini, P | 1 |
| Ughi, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Dose Escalation Study of Oral Octanoic Acid in Patients With Essential Tremor[NCT01468948] | Phase 1 | 18 participants (Actual) | Interventional | 2011-10-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for carnitine and Celiac Sprue
| Article | Year |
|---|---|
Medium-chain triglycerides: an update.
Topics: Animals; Anticonvulsants; Carnitine; Celiac Disease; Dietary Fats; Diglycerides; Enteral Nutrition; | 1982 |
Nutritional consequences of reoperative surgery in recurrent malignancy.
Topics: Adult; Carnitine; Celiac Disease; Female; Gastrointestinal Neoplasms; Humans; Intestinal Fistula; La | 1993 |
1 trial available for carnitine and Celiac Sprue
| Article | Year |
|---|---|
L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study.
Topics: Administration, Oral; Adult; Biomarkers; Biopsy; Carnitine; Celiac Disease; Chromatography, High Pre | 2007 |
5 other studies available for carnitine and Celiac Sprue
| Article | Year |
|---|---|
Clinical quiz. Secondary carnitine deficiency due to celiac disease.
Topics: Carnitine; Celiac Disease; Glutens; Humans; Infant; Male; Motor Activity; Muscle Hypotonia; Muscles; | 2003 |
Encephalopathy due to carnitine deficiency in an adult patient with gluten enteropathy.
Topics: Biopsy; Brain Diseases, Metabolic; Carnitine; Celiac Disease; Diagnosis, Differential; Electroenceph | 2006 |
Plasma carnitine ester profile in adult celiac disease patients maintained on long-term gluten free diet.
Topics: Adult; Carnitine; Celiac Disease; Diet; Esters; Female; Glutens; Humans; Male | 2005 |
Serum carnitine concentrations in coeliac disease.
Topics: Adolescent; Carnitine; Celiac Disease; Child; Child, Preschool; Duodenum; Female; Gastrointestinal D | 1993 |
[Plasma L-carnitine levels in children with celiac disease].
Topics: Adolescent; Carnitine; Celiac Disease; Child; Child, Preschool; Humans; Infant | 1992 |